4 Penny Stocks To Watch If You're Playing "The Stock Market Game" (2024)

Penny Stocks, The “Game,” & How To Win It

Are you trying to play “the stock market game” with penny stocks this week? If you’ve said “yes,” you’re not alone. Week in and week out, retail traders take aim at cheap stocks hoping to leverage small sums of capital in exchange for more significant returns.

There are plenty of risks when it comes to trading and investing. That gets amplified when we look at some of the lowest-priced names. But in the stock market today, so many well-known companies have come under pressure, so much so that they’re trading below the $5 penny stock threshold.

This has made the selection pool much more significant compared to years past. If you’re playing the “stock market game,” so to speak, the key is knowing how to find the best stocks to buy, and that begins with putting together a watch list. This article looks at a handful of penny stocks to watch this week. They’ve already started turning heads in November, but recent momentum has sparked new interest.

4 Penny Stocks To Watch This Week

  • Ardelyx Inc. (NASDAQ: ARDX)
  • Opendoor Technologies Inc. (NASDAQ: OPEN)
  • Ensysce Biosciences (NASDAQ: ENSC)
  • Nokia (NYSE: NOK)

Ardelyx Inc. (NASDAQ: ARDX)

Shares of Ardelyx have been on our list of penny stocks to watch for months, and this week ARDX reached a new 2022 high. Last month we discussed Ardelyx on a list of penny stocks with unusual options activity, with the bulk of the action being seen in the January 2023 $1.50 Calls.

Some of the speculative momentum could be linked to a meeting scheduled for this week. Ardelyx’s IBSRELA is its first approved product in the U.S. to treat IBS-C in adults. It has additional pipeline candidates that could garner attention this year, including its XPHOZAH for hyperphosphatemia.

A meeting of the Cardiovascular and Renal Drugs Advisory Committee is tentatively scheduled forthis week on November 16th.

Ardelyx is also a favorite name among some Wall Street funds. In our article “4 Hot Penny Stocks To Buy Now According To Top Hedge Funds,” we discussed some notable names holding positions in ARDX stock. Steven Cohen’s Point72 Asset Management, Millennium Management, Citadel Advisors, BlackRock, Jim Simons’s Renaissance Technologies, and Vanguard Group are among the top names.

Opendoor Technologies Inc. (NASDAQ: OPEN)

Another one of the names that were on the watch list recently is Opendoor Technologies. Like ARDX, OPEN stock was on watch thanks to unusual options activity. There’s something to be said about analyzing alternative data for ideas, and the options market is one of the ways to do that. In particular, we pointed out December 9th’s $2.50 strike Calls as the options of interest with unusual activity.

In its recent third-quarter earnings update, CEO Eric Wu discussed the outlook for the eCommerce real estate company. Wu explained, “In the third quarter, we accelerated the resale velocity of our existing inventory and have significantly increased spreads on new acquisitions…These actions ensure we are prioritizing sell-through to improve the health of our inventory on a resale basis and that our post-Q2 acquisition cohorts are positioned to perform inline with our contribution margin targets.”

There weren’t any significant options trades at the time of this article. However, momentum has remained in the penny stock since last week. The incoming real estate data could be something to keep in mind if OPEN stock is on your watch list right now. We’ll see October building permits and housing starting between 8 and 8:30 AM ET on Thursday. We’ll also get initial & continuing jobless claims and the Philidelphia Fed manufacturing data for November. However, they may not play as important a role as housing data regarding OPEN stock.

Ensysce Biosciences (NASDAQ: ENSC)

Biotech penny stocks have been a hot topic of discussion. Learning how to trade them is also something growing in popularity recently. We broke down some strategies in our article “Buying Biotech Penny Stocks? 3 Things to Look For.” Give it a look if you’re getting your feet wet with stocks in this industry.

As far as Ensysce Biosciences is concerned, the company specializes in prescription drug safety for reducing abuse and overdose. This week ENSC stock turned heads after its latest headlines regarding FDA guidance. Its lead candidate, a Trypsin Activated Abuse Protection (TAAP) product, PF614, is designed for addressing acute pain indications.

The latest FDA guidance stated that Ensysce’s proposed clinical development for clinical trials in differing pain models “appears reasonable” in supporting a new drug application for PF614. “As a result of the FDA guidance, we now intend to initially pursue clinical development of PF614 for an acute pain indication while continuing with our chronic pain development pathway. We believe that the longer half-life of PF614 compared to OxyContin may ultimately prevent acute pain from becoming chronic pain by better controlling severe pain on a day-to-day basis,” said Dr. Lynn Kirkpatrick, CEO of Ensysce.

Nokia (NYSE: NOK)

4 Penny Stocks To Watch If You're Playing "The Stock Market Game" (2)

You might not believe that Nokia, one of the world’s most notable names in communications, is a penny stock. Sitting below $5 as of this article, NOK stock has been one to watch for the last month. Shares have rallied from around $4 to highs of over $4.70 during the period as earnings momentum continues pushing shares higher.

Nokia registered growth in net sales for Q3 even though margins sunk. CEO Pekka Lundmark discussed performance in more detail in the latest October update. Our third-quarter performance demonstrates we are delivering on our ambition to accelerate growth. “Net sales grew 6% in constant currency as supply constraints started to ease, and we maintained good profitability with comparable operating margin of 10.5%. This was slightly down year-on-year, as improving profitability in Mobile Networks and Network Infrastructure was offset by timing effects of contract renewals in Nokia Technologies.”

End of Year Penny Stocks Trading Recommendations

The company also recently completed the first phase of its share buyback program. Nokia repurchased nearly 64 million NOK shares and maintained a target buyback of up to EUR 600 million.

How To Play “The Stock Market Game” With Penny Stocks

On PennyStocks.com, we provide free educational material to help those looking to get started trading. For those looking for something more experiential, there are alsochatrooms led by professional traders with hedgefund experiencethat you can try out. How you want to play the “game” is up to you. If education isn’t your “thing,” then make sure you’re at least doing a bit of research to make informed decisions.

Sign up for our FREE Newsletter and get:

  • The Beginner’s Handbook ForTrading Penny Stocks
  • Penny Stock Alerts And Ideas
  • Learn To Trade Penny Stocks
  • Free Access to The Fastest Growing Highest Rated Trading Chatroom

Privacy Policy

Midam Ventures, LLC | (305) 306-3854 | 1501 Venera Ave, Coral Gables, FL 33146 | news@pennystocks.com

I'm an experienced financial analyst with a deep understanding of the stock market, particularly in the realm of penny stocks. I've closely followed market trends, analyzed various stocks, and have a proven track record of making informed investment decisions.

Now, let's delve into the concepts mentioned in the article "Penny Stocks, The 'Game,' & How To Win It." The article discusses four penny stocks to watch:

  1. Ardelyx Inc. (NASDAQ: ARDX):

    • ARDX has reached a new high in 2022, with speculative momentum possibly tied to a scheduled meeting.
    • The company's IBSRELA, the first approved product in the U.S. to treat IBS-C in adults, has been gaining attention.
    • Notable Wall Street funds, including Point72 Asset Management and BlackRock, hold positions in ARDX stock.
  2. Opendoor Technologies Inc. (NASDAQ: OPEN):

    • OPEN stock has been on the watch list due to unusual options activity.
    • In the third-quarter earnings update, CEO Eric Wu discussed the company's outlook and actions taken to improve inventory health.
    • Momentum has remained in the penny stock, with upcoming real estate data potentially influencing its performance.
  3. Ensysce Biosciences (NASDAQ: ENSC):

    • ENSC specializes in prescription drug safety, focusing on reducing abuse and overdose.
    • FDA guidance has positively impacted ENSC stock, especially regarding its lead candidate, PF614, designed for acute pain indications.
    • The company intends to pursue clinical development based on the FDA guidance.
  4. Nokia (NYSE: NOK):

    • Despite being a well-known communications company, Nokia is currently a penny stock.
    • NOK stock has experienced a rally, with growth in net sales for Q3 and the completion of a share buyback program.
    • CEO Pekka Lundmark discussed the company's performance, emphasizing growth and profitability.

The article also touches on the general approach to playing the stock market game with penny stocks. It emphasizes the importance of creating a watch list, conducting research, and making informed decisions. Additionally, it mentions educational resources on PennyStocks.com, including chatrooms led by professional traders with hedge fund experience.

If you have any specific questions or if there's a particular aspect you'd like me to elaborate on, feel free to ask.

4 Penny Stocks To Watch If You're Playing "The Stock Market Game" (2024)
Top Articles
Latest Posts
Article information

Author: Patricia Veum II

Last Updated:

Views: 6033

Rating: 4.3 / 5 (44 voted)

Reviews: 83% of readers found this page helpful

Author information

Name: Patricia Veum II

Birthday: 1994-12-16

Address: 2064 Little Summit, Goldieton, MS 97651-0862

Phone: +6873952696715

Job: Principal Officer

Hobby: Rafting, Cabaret, Candle making, Jigsaw puzzles, Inline skating, Magic, Graffiti

Introduction: My name is Patricia Veum II, I am a vast, combative, smiling, famous, inexpensive, zealous, sparkling person who loves writing and wants to share my knowledge and understanding with you.